Copyright
©The Author(s) 2024.
World J Clin Oncol. Mar 24, 2024; 15(3): 434-446
Published online Mar 24, 2024. doi: 10.5306/wjco.v15.i3.434
Published online Mar 24, 2024. doi: 10.5306/wjco.v15.i3.434
Gene | Gene set | Coef | Hazard ratio | Z | P value |
ATG10 | Ubiquitin-conjugating enzyme (E2) | 0.48387 | 1.62234 | 2.364 | 0.0181 |
PSMA8 | Proteasome | 0.20721 | 1.23024 | 1.962 | 0.0497 |
PSMB2 | Proteasome | 0.66763 | 1.94962 | 2.483 | 0.013 |
USP17L2 | Deubiquitinating enzyme (DUB) | -2.8057 | 0.06046 | -3.048 | 0.0023 |
USP8 | Deubiquitinating enzyme (DUB) | -0.46594 | 0.62755 | -1.701 | 0.0889 |
- Citation: Li H, Ma YP, Wang HL, Tian CJ, Guo YX, Zhang HB, Liu XM, Liu PF. Establishment of a prognosis predictive model for liver cancer based on expression of genes involved in the ubiquitin-proteasome pathway. World J Clin Oncol 2024; 15(3): 434-446
- URL: https://www.wjgnet.com/2218-4333/full/v15/i3/434.htm
- DOI: https://dx.doi.org/10.5306/wjco.v15.i3.434